Sutro Biopharma's total assets for Q3 2025 were $209.66M, a decrease of -20.09% from the previous quarter. STRO total liabilities were $296.93M for the fiscal quarter, a 0.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.